Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.35
-0.4200-0.69%
Volume:137.29K
Turnover:8.29M
Market Cap:5.83B
PE:-12.82
High:61.05
Open:60.77
Low:60.03
Close:60.77
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:2.58
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.69
PE(LYR):-13.83

Loading ...

Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?

Simply Wall St.
·
Aug 19

Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550

Reuters
·
Aug 14

J.P. Morgan Remains a Buy on Xenon (XENE)

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)

TIPRANKS
·
Aug 10

Analysts Are Bullish on These Healthcare Stocks: Oculis Holding (OCS), Xenon (XENE)

TIPRANKS
·
Aug 08

Xenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says

MT Newswires Live
·
Aug 08

Evercore ISI Reaffirms Their Buy Rating on Xenon (XENE)

TIPRANKS
·
Aug 08

Wedbush Adjusts PTon Xenon Pharmaceuticals to $71 From $63, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

RBC Adjusts Xenon Pharmaceuticals PT to $81 From $82, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Earnings Flash (XENE) Xenon Posts Q2 Loss Per Share $1.11, vs. FactSet Est of $1.14 Loss

MT Newswires Live
·
Aug 07

Xenon Pharmaceuticals reports Q2 EPS ($1.11), consensus ($1.16)

TIPRANKS
·
Aug 07

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26

Reuters
·
Aug 07

Xenon Pharmaceuticals Q2 EPS $(1.11) Beats $(1.15) Estimate

Benzinga Earnings
·
Aug 07

Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million

Reuters
·
Aug 07

Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million

THOMSON REUTERS
·
Aug 07

Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029

THOMSON REUTERS
·
Aug 07

Xenon Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 07

Xenon Pharma Grants 32,758 Inducement Stock Options, 19,013 RSUs to New Hires

Reuters
·
Aug 01